Last reviewed · How we verify
Investigational Influenza Vaccine 1
Investigational Influenza Vaccine 1 is a Biologic drug developed by ModernaTX, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Investigational Influenza Vaccine 1 |
|---|---|
| Sponsor | ModernaTX, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza (PHASE2)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- A Study to Learn About mRNA Vaccines Against Influenza in Adults (PHASE2)
- Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae (PHASE2)
- Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test (NA)
- Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults (PHASE1)
- Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. (PHASE2)
- A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Investigational Influenza Vaccine 1 CI brief — competitive landscape report
- Investigational Influenza Vaccine 1 updates RSS · CI watch RSS
- ModernaTX, Inc. portfolio CI
Frequently asked questions about Investigational Influenza Vaccine 1
What is Investigational Influenza Vaccine 1?
Investigational Influenza Vaccine 1 is a Biologic drug developed by ModernaTX, Inc..
Who makes Investigational Influenza Vaccine 1?
Investigational Influenza Vaccine 1 is developed by ModernaTX, Inc. (see full ModernaTX, Inc. pipeline at /company/modernatx-inc).
What development phase is Investigational Influenza Vaccine 1 in?
Investigational Influenza Vaccine 1 is in Phase 1.